6505--Intent To Sole Source - LU177 Vipivotide Tetra (Pluvicto)
Special Notice Posted
- Solicitation number
- 36C24223Q0707
- Agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
Notice text
The Network Contracting Office (NCO) 2, Department of Veterans Affairs intends to award a firm-fixed-price sole source contract with Advanced Accelerator Applications USA, Inc., a large business, for the purchase of LU177 Vipivotide Tetra (Pluvicto) delivery/service for
VA Western New York Healthcare System
Buffalo VAMC
Nuclear Medicine
3495 Bailey Avenue
Buffalo, NY 14215
This sole source determination is in accordance with FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Advanced Accelerator Applications USA, Inc. is the only known authorized supplier for LU177 Vipivotide Tetra (Pluvicto).
The North American Industry Classification System (NAICS) code for this procurement is 325412 and the size standard is 1,250 employees.
Statement of Need: The New York/New Jersey Healthcare System Veterans Integrated Service Network (VISN) 2, in support of VA Buffalo Medical Center has a requirement for LU177 Vipivotide Tetra (Pluvicto) delivery/service. Capable contractors must primarily be engaged in the business of radiopharmaceutical therapy resell in a Medical Center environment.
Federal Supply Schedule: If your firm provides the radiopharmaceutical therapy on GSA Federal Supply Schedule, please provide applicable contract number and identify which supply/service are applicable to that FSS contract.
Technical abilities:
Contractor must be either the manufacturer or fully licensed, authorized and have selling permission for the reagent kits.
Contractor shall be FDA certified
No solicitation package will be issued at this time. This notice of intent is not a request for competitive quotes; however, interested parties may identify their interest and technical capability to respond to this requirement. Interested vendors that can meet this requirement, should identify their interest and capability, and respond to this notice by 2:00 PM EST on May 12, 2023. Interested vendors must send a capability statement, no more than one page in length; to include Company Name, UEI Number, Socioeconomic Category, brief description of your business entities capability to provide these items. All information shall be provided at no cost or obligation to the Government.
Files
| File | Type | Posted |
|---|---|---|
| 36C24223Q0707.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity